Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Change in Cash: 2010-2024

Historic Change in Cash for CorMedix (CRMD) over the last 14 years, with Dec 2024 value amounting to -$3.1 million.

  • CorMedix's Change in Cash fell 1729.56% to -$109.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year increase of 153.55%. This contributed to the annual value of -$3.1 million for FY2024, which is 783.93% down from last year.
  • CorMedix's Change in Cash amounted to -$3.1 million in FY2024, which was down 783.93% from $448,447 recorded in FY2023.
  • Over the past 5 years, CorMedix's Change in Cash peaked at $25.6 million during FY2020, and registered a low of -$10.2 million during FY2022.
  • For the 3-year period, CorMedix's Change in Cash averaged around -$4.3 million, with its median value being -$3.1 million (2024).
  • In the last 5 years, CorMedix's Change in Cash surged by 2,113.30% in 2020 and then crashed by 783.93% in 2024.
  • Yearly analysis of 5 years shows CorMedix's Change in Cash stood at $25.6 million in 2020, then tumbled by 55.21% to $11.5 million in 2021, then tumbled by 188.84% to -$10.2 million in 2022, then spiked by 104.41% to $448,447 in 2023, then crashed by 783.93% to -$3.1 million in 2024.